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Mammalian pain-related sensory neurons are
derived from TrkA lineage neurons located in the
dorsal root ganglion. These neurons project to pe-
ripheral targets throughout the body, which can be
divided into superficial and deep tissues. Here, we
find that the transcription factor Runx1 is required
for the development of many epidermis-projecting
TrkA lineage neurons. Accordingly, knockout of
Runx1 leads to the selective loss of sensory inner-
vation to the epidermis, whereas deep tissue
innervation and two types of deep tissue pain are
unaffected. Within these cutaneous neurons, Runx1
suppresses a large molecular program normally
associated with sensory neurons that innervate
deep tissues, such as muscle and visceral organs.
Ectopic expression of Runx1 in these deep sensory
neurons causes a loss of this molecular program
and marked deficits in deep tissue pain. Thus, this
study provides insight into a genetic program con-
trolling the segregation of cutaneous versus deep tis-
sue pain pathways.
INTRODUCTION
The dorsal root ganglia (DRGs) are composed of a heteroge-
neous population of primary sensory neurons, including noci-
ceptors, mechanoreceptors, thermoceptors, and pruriceptors
(Basbaum et al., 2009; Delmas et al., 2011; Marmige`re and
Ernfors, 2007). The peripheral targets of DRG neurons can be
divided into two main zones based on a radial topographical
body plan: (1) superficial tissues, the largest being the epidermis
of the skin and (2) deep tissues, including the dermis, muscle,
bone, and visceral organs. The rationale for this division isCell Re2-fold. First, the superficial tissues and the deep tissues stem
from distinct germ layers, with the epidermis derived from the
ectoderm, and the deep tissues derived from the mesoderm
(dermis, muscle, bone, muscular layers of visceral organs) and
endoderm (mucosal layers of visceral organs) (Gilbert, 2000).
Second, with respect to pain, a focus of this study, there are
well-documented clinical differences between cutaneous pain
and deep tissue pain, such as cutaneous pain generating more
reflexive or protective responses, and deep tissue pain being
associated with more emotional and autonomic responses
(Bove et al., 2009; McMahon et al., 1995; Ness and Gebhart,
1990; Robinson and Gebhart, 2008).
In mammals, all pain neurons are derived from TrkA lineage
neurons, because a mutation in TrkA (the receptor for the nerve
growth factor) leads to congenital pain insensitivity (Indo, 2012).
In the past decade, progress has been made in defining TrkA
lineage neurons that selectively innervate cutaneous structures.
For example, polymodal nociceptors marked by the expression
of the G-protein-coupled receptors Mrgprd, Mrgprb4, and
Mrgpra3 innervate mainly the skin epidermis (Cavanaugh et al.,
2009; Han et al., 2013; Rau et al., 2009; Zylka et al., 2005). In
contrast, no markers have been identified that are exclusively
associated with deep tissue TrkA lineage neurons. Deep tissue
DRG neurons do express genes such as CGRP, TRPV1, and
ASIC3, but these genes are also expressed in cutaneous DRG
neurons (Bennett et al., 1996; Castan˜eda-Corral et al., 2011;
Christianson et al., 2006a; Jimenez-Andrade et al., 2010; Malin
et al., 2011; McCoy et al., 2012; McMahon et al., 1994; Molliver
et al., 2005). The dearth of information on deep tissue pain-
related sensory neurons belies their clinical relevance, because
most medical cases of pain relate to muscle, bone, and visceral
pain, as opposed to cutaneous pain (Ness and Gebhart, 1990).
The genetic program that controls the segregation of cuta-
neous versus deep tissue pain-related sensory neurons is still
poorly understood. The runt domain transcription factor Runx1
is initially expressed in 93% of embryonic TrkA-expressing
neurons (Abdel Samad et al., 2010), but the expression ofports 5, 1353–1364, December 12, 2013 ª2013 The Authors 1353
Figure 1. Cellular Characterization of the Runx1-Suppressed Genes Cbhp2, Chrna7, Pcdh21, Serpinb1b, Prokr2, and Ptgir
(A) In situ hybridization (ISH) with indicated probes on adult lumbar DRG sections of wild-type (WT) or Runx1 conditional knockout (CKO) mice.
(B) mRNAs of Runx1-suppressed genes (red) detected by ISH were excluded from Mrpgrd+ neurons marked by GFP expression (green, fromMrpgrdGFP/+mice)
and from VGLUT3+ neurons marked by Tomato expression (pseudo green, from VGLUT3Cre;RosaTomato fate-mapping mice) but were detected in subsets of
(legend continued on next page)
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Runx1 and TrkA is reciprocally extinguished in distinct subsets of
these neurons during perinatal and postnatal development (Lal-
lemend and Ernfors, 2012; Liu and Ma, 2011). Functionally,
Runx1 is necessary for the specification of a large cohort of sen-
sory neurons involved with pain, itch, and temperature sensation
(Liu and Ma, 2011). In this study, we will present a series of evi-
dence supporting a pivotal role for Runx1 in controlling the
segregation of cutaneous versus deep tissue pain sensory
neurons.
RESULTS
Identification of Two Molecular Programs Associated
with Cutaneous versus Deep Tissue Sensory Neurons
We first used microarray analysis to determine the extent to
which Runx1 regulates gene expression on a genome-wide
scale. Adult Runx1 conditional knockouts (Runx1F/F;Wnt1Cre,
referred to here as Runx1 CKO) were used, in which the deletion
of Runx1 is driven by Wnt-1-cre expression in premigratory neu-
ral crest cells, including the progenitors of DRG neurons (Chen
et al., 2006). By using the dCHIP software (Li and Wong, 2001)
to compare the gene expression profiles of DRGs from Runx1
CKO mice and their wild-type (WT) littermates, we identified (1)
over 200 genes that are markedly downregulated in the Runx1
CKO (Table S1), referred to here as ‘‘Runx1-dependent’’ genes,
and (2) over 100 genes whose expression is increased in the
Runx1 CKO, referred to here as ‘‘Runx1-suppressed’’ genes
(Table S2). The quality of this microarray data is validated by
the fact that the genes listed in Table S1 include most of the
known Runx1-dependent genes.
Previous genetic marking studies showed that three Runx1-
dependent genes, Mrgprd, Mrgprb4, and Mrgpra3, are ex-
pressed in DRG neurons that sense mechanical pain, itch, and/
or pleasant touch, and these neurons innervate exclusively the
epidermal tissues, with the majority of the glabrous epidermal fi-
bers beingmarked byMrgprd (Cavanaugh et al., 2009; Han et al.,
2013; Liu et al., 2007; Vrontou et al., 2013; Zylka et al., 2005).
Double staining showed that a large set of identified Runx1-
dependent genes was mainly expressed in Mrpgrd+ polymodal
nociceptors (Figure S1A). The Runx1-dependent gene set also
includes those encoding vesicular glutamate transporter
VGLUT3, which is expressed in unmyelinated low-threshold
mechanoreceptors (Li et al., 2011; Lou et al., 2013; Seal et al.,
2009). Genetic marking analysis showed that VGLUT3-express-
ing DRG neurons innervate the hair follicles and the skin
epidermis (Li et al., 2011; Lou et al., 2013), tissues fully or partly
derived from the ectoderm (Gilbert, 2000). Here, we further foundneurons retrogradely labeled from the gastrocnemius muscle and/or from the blad
neurons expressing or not expressing the indicated gene, respectively.
(C) The percentage of Mrgprd-GFP+, VGLUT3-Tomato+, or neurons retrogradely l
suppressed gene. nR 3 animals for each analysis. Asterisks indicate a significa
parison with that in Mrgprd-GFP+ or VGLUT3-Tomato+ neurons. Error bars, SEM
121–208 muscle retrogradely labeled cells, and 156–364 bladder retrogradely la
(D) Genetic marking of the innervation of Prokr2 lineage neurons by using Prokr2C
of Prokr2 lineage neurons (red) are virtually excluded from the epidermis (epi,
uncharacterized group of Prokr2-expressing cells in the dermis (der). Tomato+ ne
For bladder and colon: mus, muscular layer; uro, urothelial layer; and muc, muco
All scale bars represent 50 mm. See also Figures S1 and S2.
Cell Rethat VGLUT3 lineage neurons, marked by the expression of the
Tomato reporter protein, do not innervate the deep tissues,
such as the muscle and the bladder (Figure S1B). Consistently,
the expression of Runx1 itself is excluded from adult sensory
neurons innervating deep tissues (see below). These data
suggest that Runx1-dependent DRG neurons preferentially
innervate the superficial ectodermal tissues.
The microarray analysis also revealed over 100 Runx1-sup-
pressed genes, whose expression is markedly upregulated in
the Runx1 CKO (Table S2). We validated 25 of these genes by
in situ hybridization, and the derepression of these genes in
the Runx1 CKO was clearly indicated by their dramatic expan-
sion into neurons labeled by the isolectin B4 (IB4) (Figures 1A
and S1; data not shown). Many Runx1-suppressed genes are
expressed in a small subset of DRG neurons, as exemplified
by Cbhp2, Chrna7, Pcdh21, Serpinb1b, Prokr2, and Ptgir (Fig-
ure 1A). Previous genetic fate mapping showed that 80% of
DRG neurons express persistently or transiently the sodium
channel Nav1.8, including the majority of TrkA lineage neurons
(Agarwal et al., 2004; Liu et al., 2010). We found that expression
of Cbhp2, Chrna7, Pcdh21, Serpinb1b, Prokr2, and Ptgir is
nearly entirely confined to Nav1.8 lineage neurons (Figure S1D).
A double staining with CGRP, a peptidergic neuron marker,
showed that, although some of these genes are mostly peptider-
gic (for example, Pcdh21 and Ptgir), others (for example, Ser-
pinb1b) are expressed largely in CGRP neurons (Figure S1D).
A double staining with TrkA showed that 85% and 45% of
Ptgir+ and Serpinb1b+ neurons coexpressed TrkA, respectively,
suggesting that at least a subset of neurons expressing Runx1-
suppressed genes represent TrkA lineage neurons (Figure S1E).
As mentioned above, Mrgprd+ and VGLUT3+ neurons, which
compose 30% and 10%–19% of DRG neurons, respectively,
innervate exclusively the ectodermal tissues (Li et al., 2011; Liu
et al., 2008; Lou et al., 2013; Seal et al., 2009; Zylka et al.,
2005). Expression of Cbhp2, Chrna7, Pcdh21, Serpinb1b,
Prokr2, and Ptgir was not detected in either Mrgprd+ or VGLUT3
lineage neurons, as genetically marked by GFP and Tomato re-
porters, respectively (Figure 1B). Expression of these Runx1-
suppressed genes is therefore excluded from two major classes
of cutaneous DRG neurons.
We next asked whether Runx1-suppressed genes might be
expressed in deep tissue DRG neurons. To determine this, we
tested the expression of Runx1-suppressed genes in DRG neu-
rons retrogradely labeled from various deep tissues, including
the gastrocnemius muscle, bladder, and colon. To ensure that
there was no leakage of the fluorescent tracer into the skin,
particularly with the injections into the gastrocnemius, only thoseder (green). Arrows and arrowheads indicate examples of retrogradely labeled
abeled from the gastrocnemius or bladder that expressed the indicated Runx1-
nt enrichment of expression in muscle and/or bladder DRG neurons, in com-
; *p < 0.05. 924–1,124 Mrpgrd-GFP+ cells, 674–1,129 VGLUT3-Tomato+ cells,
beled cells were counted for each gene.
re;RosaTomato fate-mapping mice (see also Figure S2). Tomato+ nerve terminals
thin glabrous skin), with cell nuclei revealed by DAPI staining (blue). Note an
rve terminals were detected in the gastrocnemius, the bladder, and the colon.
sal layer.
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DRGs whose retrogradely labeled neurons showed no or mini-
mal overlap with the cutaneous neuron marker Mrgprd were
used for analysis (Figure S1F). The results revealed that one
Runx1-suppressed gene—Ptgir—was expressed in 63% and
36% of neurons retrogradely labeled from the bladder and the
muscle, respectively (Figures 1B and 1C). Expression of five
other Runx1-suppressed genes analyzed—Cbhp2, Chrna7,
Pcdh21, Serpinb1b, and Prokr2—was detected in 10%–50%
of neurons retrogradely labeled from the muscle. It should be
noted that Nav1.8 lineage neurons do not include proprioceptors
marked by the expression of parvalbumin (Agarwal et al., 2004;
Liu et al., 2010). Because Runx1-suppressed genes are confined
to Nav1.8 lineage neurons (Figure S1), we can conclude that
muscle afferents expressing Runx1-suppressed genes do not
represent proprioceptors. Statistic analyses show that expres-
sion of these six genes is significantly enriched in neurons inner-
vating muscle and/or bladder compared to the virtual lack of
their expression in epidermis-projecting Mrgprd+ and VGLUT3+
neurons (Figure 1C).
To unambiguously determine whether there are Runx1-sup-
pressed genes expressed exclusively in deep tissue DRG neu-
rons, we used genetic tracing to directly visualize the peripheral
innervation of neurons expressing one of the Runx1-suppressed
genes Prokr2, encoding a receptor for the prokineticin peptide
(Negri and Lattanzi, 2012). We crossed Prokr2Cre transgenic
mice (GENSAT, http://www.gensat.org/Cre.jsp/), in which the
Cre recombinase is driven from the Prokr2 promoter, with the
Cre-dependent Rosa26LSL-tdTomato reporter mice to generate
mice referred to here as Prokr2Cre;RosaTomato (Madisen et al.,
2010). In these mice, neurons expressing Prokr2 were perma-
nently marked by Tomato expression irrespective of persistent
or transient Prokr2 expression. Most Prokr2+ neurons, as de-
tected by in situ hybridization, are within Tomato+ DRG neurons
in the Prokr2Cre;RosaTomato mice (Figure S2). However, there are
a greater number of Tomato+ neurons than neurons exhibiting
Prokr2 mRNA signal, which could either reflect transient devel-
opmental expression of Prokr2, which is captured by the
Prokr2Cre;RosaTomato line, or higher detection sensitivity of the
Tomato reporter. Regardless, like Prokr2 mRNA, Tomato signal
was observed in primarily CGRP+ neurons and largely excluded
from IB4+ neurons (Figure S2).
Interestingly, Tomato+ fibers were rarely detected in the skin
epidermis of glabrous skin (thin or thick) or in the epidermis of
hairy skin in Prokr2Cre;RosaTomato mice, although a mesh of
Tomato+ local cells were observed in the dermis (Figure 1D;
data not shown). In contrast, Tomato+ fibers were visible in the
gastrocnemius and the marrow of the femur (Figure 1D; data
not shown). In the bladder, there are Tomato+ fibers mostly in
the muscular layer with occasional fibers in the urothelial layer
(Figure 1D). Similarly, Tomato+ fibers are detectable in the colon,
but primarily in the muscular layer (Figure 1D). Among the mice
tested, none showed neuronal labeling in the sympathetic
ganglia (Figure S1G). These Tomato+ fibers in muscle and
bladder are thus derived from the DRG. It should be noted that
adult Prokr2 expression is detected in DRG neurons retrogradely
labeled from the muscle, but not from the bladder or the colon
(see Figure 1B). Collectively, these data suggest that Prokr2-To-
mato fibers observed in these visceral tissues may represent1356 Cell Reports 5, 1353–1364, December 12, 2013 ª2013 The Autneurons expressing Prokr2 transiently, whereas those fibers
observed in muscle should at least partly be derived from neu-
rons with persistent Prokr2 expression. In some rare instances,
perhaps due to the transgenic nature of the Prokr2Cre line, a
Prokr2Cre;RosaTomato progeny exhibited a significantly larger
number of labeled DRG neurons with some innervation to the
epidermis; however, this ‘‘leaky’’ expression represented only
a small minority of the animals examined (data not shown). Taken
together, these data suggest that Prokr2 lineage neurons inner-
vate preferentially the deep tissues and do not innervate the skin
epidermis.
Selective Reduction of Epidermal Innervation in Runx1
CKO Mice
The finding that Runx1-dependent genes are preferentially asso-
ciated with cutaneous sensory neurons led us to ask whether
Runx1 plays a role in controlling the innervation of these neurons
to their peripheral targets. To answer this question, we first
examined the innervation to the epidermis of the glabrous hind-
paw in Runx1 CKOmice, using immunostaining against the pan-
neuronal marker PGP9.5 to visualize sensory fibers. In the Runx1
CKO, there is a 50% loss of fibers entering the epidermis (Fig-
ure 2A). Notably, those fibers that terminate in the most superfi-
cial layer (stratum granulosum) and exhibit wavy and branching
morphologies are essentially eliminated; such fibers are derived
from Mrgprd+ polymodal nociceptors (Zylka et al., 2005), which
represent the largest group of Runx1-dependent DRG neurons.
This loss could be observed at every developmental stage
examined, starting from P0, the stage at which fibers appear to
first cross the basal layer of the epidermis (Figure 2A; data not
shown). Thus, Runx1 is indeed essential for DRG neurons to
innervate cutaneous targets, specifically the most superficial
lamina within the epidermis.
To visualize deep tissue innervation, we needed to mark
sensory fibers derived from DRG neurons, but not neurons in
sympathetic or enteric ganglia. To do this, we crossed Runx1F/F
mice with Nav1.8Cre mice and the Cre-dependent TauLSL-mEGFP
reporter line (Hippenmeyer et al., 2005). In the resulting
Runx1F/F;Nav1.8Cre;TauLSL-mEGFP/+ mice, Runx1 is removed
in Nav1.8Cre-expressing neurons whose nerve terminals are
marked by the expression of the membrane-associated
enhanced green fluorescent protein or mEGFP. Nav1.8Cre was
chosen because it is expressed in 80% of DRG neurons,
including most TrkA lineage neurons, but not in sympathetic or
enteric neurons (Agarwal et al., 2004; Liu et al., 2010). Wnt1Cre,
used above to eliminate Runx1 in neural crest cell precur-
sors, is not suitable for this purpose because Wnt1Cre is
also expressed in sympathetic and enteric neurons. As in
Runx1F/F;WntCre CKO mice, Runx1F/F;Nav1.8Cre;TauLSL-mEGFP/+
CKO mice showed a similar reduction in epidermal fiber density
(Figure 2B). In contrast, no reduction in fiber density in the
colon or the bladder was observed in Runx1F/F;Nav1.8Cre;
TauLSL-mEGFP/+ mice compared to control mice (Nav1.8Cre;
TauLSL-mEGFP/+) (Figure 2B). We also did not detect qualitative
differences in innervation to the periosteum or bone marrow
(data not shown). Thus, although Runx1 is necessary for sensory
innervation to the epidermis, it is dispensable for sensory inner-
vation to the deep tissues.hors
Figure 2. Runx1 Is Required Selectively for Sensory Innervation to the Epidermis
(A) Sensory innervation to the thin glabrous epidermis of the hindpaw at P0 and P30 in the WT (Runx1F/F) and early CKO (Runx1F/F;Wnt1Cre), represented by
PGP9.5 staining (green). Keratinocytes are represented by DAPI staining (gray). The number of PGP9.5+ fibers/field of 100 DAPI+ basal keratinocytes at P30 was
quantitated. Error bars, SEM; **p < 0.01.
(B) Sensory innervation to indicated regions ofWT and late CKOmice at P30, by PGP9.5 staining for epidermis and byGFP immunostaining for colon and bladder.
For the epidermis, WT is Runx1F/F, and CKO is Runx1F/F;Nav1.8Cre. The number of PGP9.5+ fibers/field of 100 DAPI+ basal keratinocytes at P30 was quantitated.
For the colon and the bladder, WT is Nav1.8Cre;TauLSL-,EGFP/+, and CKO is Runx1F/F;Nav1.8Cre;TauLSL-,EGFP/+. The percentages of colon tissue area that is
innervated and the number of fibers passing through lines drawn through the muscular layer of the bladder were quantitated. Two methods were used to
quantitate bladder innervation, both producing similar results (see Supplemental Experimental Procedures and Figure S5). n = 3 animals for each genotype. Error
bars, SEM; **p < 0.01; n.s. (not significant) pR 0.05. Methods of quantitation are detailed in Supplemental Experimental Procedures and in Figure S5.
All scale bars represent 50 mm.Impaired Deep Tissue Neuron Development in Runx1
Gain-of-Function or GOF Mutants
Runx1 is initially expressed in most, if not all, TrkA lineage neu-
rons, at early embryonic stages, but is downregulated in 50%
of these neurons during perinatal and postnatal development
(Liu and Ma, 2011). The association that we found between
Runx1-suppressed genes and deep tissue neurons naturally
led to the hypothesis that Runx1 itself should be either downre-Cell Regulated or excluded in these neurons. This is indeed the case as
Runx1 expression is largely absent in adult DRG neurons retro-
gradely labeled from the muscle, bladder, or the colon in marked
contrast with persistent Runx1 expression in most Mrgprd+ and
VGLUT3+ cutaneous sensory neurons (Figure 3A).
We next examined whether Runx1 downregulation or exclu-
sion is necessary for the development of deep tissue neurons.
For this line of study, we used Nav1.8Cre;TauLSL-Runx1/+ mice asports 5, 1353–1364, December 12, 2013 ª2013 The Authors 1357
Figure 3. Downregulation of Runx1 Is Necessary for the Development of Deep Tissue Sensory Neurons
(A) Runx1 mRNA (red) was detected in cutaneous neurons marked by Mrgprd-GFP (962 neurons counted) and VGLUT3-Tomato (844 neurons counted) but was
largely excluded from neurons retrogradely labeled from the gastrocnemius (129 neurons counted), bladder (329 neurons counted), and colon (338 neurons
counted) as indicated by the percentages of these labeled neurons expressing Runx1. Asterisks indicate a significant difference in expression between Mrgprd-
GFP+/VGLUT3-Tomato+ neurons and muscle, bladder, or colon neurons. Error bars, SEM; **p < 0.01.
(B) In situ hybridizationwith indicated probes on adult lumbar DRG sections ofWT (TauLSL-Runx1/+) orRunx1 gain-of-function (GOF,Nav1.8Cre;TauLSL-Runx1/+) mice.
(C) Sensory innervation to indicated regions of adultWT andGOFmice. For the epidermis,WT is TauLSL-Runx1/+, andGOF isNav1.8Cre;TauLSL-Runx1/+. The number of
PGP9.5+ fibers/fieldof 100DAPI+ basal keratinocyteswasquantitated. For thecolon,WT isNav1.8Cre;TauLSL-mEGFP/+, andGOF isNav1.8Cre;TauLSL-Runx1/LSL-mEGFP.
The percentage of tissue area that is innervated was quantitated. For the bladder and the gastrocnemius, WT is Nav1.8Cre;RosaLSL-Tomato/+, and GOF is
(legend continued on next page)
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a conditional Runx1 gain-of-function (Runx1 GOF) animal model
(Abdel Samad et al., 2010). In these mice, upon Cre-mediated
removal of a STOP cassette, Runx1 expression is driven from
the pan-neuronal Tau promoter; as a result, Runx1 expression
is no longer downregulated and becomes constitutive in all
Nav1.8Cre-positive neurons. In these mice the number of DRG
neurons expressing Runx1 nearly doubles and the numbers of
CGRP-, TrkA-, and TRPV1-expressing neurons are significantly
reduced (Abdel Samad et al., 2010)
We first found that the expression of the Runx1-suppressed
genes tested was either completely lost or dramatically reduced
in Runx1GOF DRGs (Figure 3B). Thus, Runx1 downregulation or
exclusion is indeed required for deep tissue neurons to acquire
proper molecular identities. We next examined the peripheral
innervation of these mice. Using PGP9.5 as a pan-neuronal
marker, we found that there is no loss and in fact, even a slight
increase, in epidermal innervation to the glabrous skin of
Runx1 GOF mice (Figure 3C).
To examine innervation to the deep tissues, we crossedRunx1
GOF mice to TauLSL-mEGFP reporter mice to create Nav1.8Cre;
TauLSL-Runx1/LSL-mEGFP GOF mice, in which Nav1.8Cre-positive
DRG neurons express Runx1 constitutively while being labeled
with mEGFP expression. Sensory innervation to the colon,
bladder, and gastrocnemius muscle is significantly reduced in
these GOF mice (Figure 3C). In the bladder, at least, this loss
of innervation was apparent as early as P0 (data not shown). It
should be noted that the GOF allele of Runx1 is also a knockin
of Runx1 at the Tau locus (Kramer et al., 2006). As a result,
the Nav1.8Cre;TauLSL-Runx1/LSL-mEGFP GOF mutant mice lose
both WT alleles of the microtubule-associated protein Tau. To
exclude the possibility that deep tissue innervation defects are
due to the loss of Tau, we generated and analyzed Nav1.8Cre;
TauLSL-mEGFP/LSL-mEGFP homozygous mice that also lose two
copies of Tau. Thesemice have normal innervation to the visceral
organs (Figure S3). This, in addition to the fact that there is no
loss of innervation to the epidermis in the Runx1GOFmice, sug-
gests that the loss of Tau does not affect peripheral sensory
innervation. Taken together, these results suggest that downre-
gulation or a lack of Runx1 expression is a prerequisite for proper
development of deep tissue DRG neurons.
Impaired Deep Tissue Pain Behavior in Runx1 GOF
Mutants
We have so far shown that, molecularly and anatomically, the
development of cutaneous and deep tissue sensory neurons is
reciprocally compromised in Runx1 CKO mice and Runx1 GOF
mice, respectively. We next asked if, behaviorally, cutaneous
versus deep tissue pain will be preferentially impaired in these
mutants.
An acute muscle pain behavior was used as one measure of
deep tissue pain. To do this, a modified hypertonic saline assay
was developed. An injection of hypertonic saline (HS) is known toNav1.8Cre;TauLSL-Runx1/+;RosaLSL-Tomato/+. The number of fibers passing through
gastrocnemius tissue area that is innervated were quantitated. Two methods we
Supplemental Experimental Procedures and Figure S5). n = 3 animals for each
Supplemental Experimental Procedures and in Figure S5.
All scale bars represent 50 mm. See also Figure S3.
Cell Recause acute leg muscle pain in humans (Graven-Nielsen and
Mense, 2001) andmore recently in rats, as reflected by pawwith-
drawal and flexing (Sa´nchez et al., 2010). We found that mice
displayed these behaviors more variably when allowed to roam
freely within a chamber. Thus, we adapted the protocol by inject-
ing HS into both gastrocnemius muscles and putting them
through a forced ambulation assay, namely, an accelerating
rotarod. In pilot experiments, C57/BL6 mice showed a 69%
drop in time spent on the rotarod after HS injection compared
to baseline. A modest 12% drop after the control injection of
isotonic saline (IS) was also observed, possibly caused by pain
generated by the needle itself (Figure S4B). The HS-induced
effect is acute, because 30min later the duration spent on the ro-
tarod returns to baseline levels. For all proceeding experiments,
times following IS versus HS injections were compared.
To determine whether Runx1 CKO or GOF mice exhibit any
baseline locomotor defects, we first measured their baseline
rotarod times compared to those of their WT littermates. All ge-
notypes tested showed similar baseline times, suggesting that
proprioceptors and neurons necessary for muscle function are
unaffected in these mutant mice (Figure S4A). After HS injection,
we found that Runx1 CKO mice exhibited a drop in time spent
on the rotarod similar to their WT littermates, suggesting that
acute muscle pain is unaffected in CKO mice (Figure 4A). In
contrast, HS injection in Runx1 GOF mice does not cause a sta-
tistically significant reduction in time spent on the rotarod (Fig-
ure 4A). We also calculated the percentage decrease in rotarod
times each animal exhibited following HS injection compared to
IS injection. Although the CKO mice and their WT littermates
showed no statistical difference in this value, the GOF mice
displayed a much smaller decrease in performance times
compared to their WT littermates (Figure 4B). Finally, whereas
their WT littermates displayed leg extensions after HS injections
(which seemed to contribute to the mice falling prematurely off
the rotarod), the GOF mice did not display such behaviors
(data not shown). Thus, this type of muscle pain is essentially
abolished in Nav1.8Cre;TauLSL-Runx1/+ GOF mice. That the
Nav1.8Cre;TauLSL-Runx1/+ GOF mice fail to respond to HS also
validates that the HS-induced fall from the rotarod is mediated
by Nav1.8-expressing neurons, rather than by an adverse effect
on proprioceptors, which, as marked by the expression of
parvalbumin, do not belong to Nav1.8 lineage neurons (Agarwal
et al., 2004; Liu et al., 2010; Shields et al., 2012; Stirling et al.,
2005).
We next tested a visceral pain behavior as another measure of
deep tissue pain, by using the intracolonic capsaicin assay (Laird
et al., 2001). In this assay, capsaicin is injected into the distal
colon via the anus, and pain is measured by the time spent
licking the posterior part of the body within a 20 min period. In
our WT strains (C57BL/6 and mixed C57/S129), we observed
increased licking in not only the abdominal area, but also the
back near the tail, the tail itself, and the feet. This licking of alines drawn through the muscular layer of the bladder and the percentage of
re used to quantitate bladder innervation, both producing similar results (see
genotype. Error bars, SEM; *p < 0.05. Methods of quantitation are detailed in
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Figure 4. Muscle and Visceral Pain Are Impaired in Runx1 GOF Mice but Not Runx1 CKO Mice
(A and B) Muscle pain assay. Time spent on an accelerating rotarod after the injection of hypertonic saline (HS) was compared with that after the injection of
isotonic saline (IS). (A) Runx1 CKO (Runx1F/F;Wnt1Cre) mice (n = 9) displayed a significant decrease in rotarod performance after HS injection as did their WT
(Runx1F/F) littermates (n = 9). Runx1 GOF (Nav1.8Cre;TauLSL-Runx1/+) mice (n = 8) displayed no significant decrease after HS injection in contrast to a significant
decrease by their WT (TauLSL-Runx1/+) littermates (n = 8). (B) The percentage decrease after HS was calculated for each animal. Shown are the comparisons of the
percentage decrease for the CKO and the GOF with their WT littermates. Error bars, SEM; *p < 0.05; **p < 0.01; n.s., pR 0.05.
(C and D) Intracolonic capsaicin injection visceral pain assay. (C) No difference in time spent licking between Runx1 CKO (Runx1F/F;Wnt1Cre) mice (n = 7)
compared to their WT (Runx1F/F) littermates (n = 6). (D) Runx1 GOF (Nav1.8Cre;TauLSL-Runx1/+) mice (n = 7) displayed a significant decrease in time spent licking
compared to their WT (TauLSL-Runx1/+) littermates (n = 7). Error bars, SEM; *p < 0.05; n.s., pR 0.05.
(E) Dynamic Runx1 expression and activity control the segregation of DRG neurons innervating the superficial ectodermal versus deep mesodermal/endodermal
tissues. Neurons expressing Runx1-dependent genes innervate the skin epidermis and hair follicles, tissues fully or partly derived from the ectoderm; these
neurons are required to sense cutaneous pain. Neurons expressing Runx1-suppressed genes innervate the mesodermal/endodermal tissues; these neurons are
required to sense deep tissue pain.
See also Figure S4.
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broad area of the posterial body is consistent with projection of
visceral sensory neurons to multiple spinal segments and the
central convergence upon the same spinal neurons that receive
inputs from cutaneous sensory afferents, thereby leading to
referred cutaneous pain (Brumovsky andGebhart, 2010; Sugiura
et al., 1989). In some cases, regardless of the genotype, there
were moments of ‘‘freezing’’; however, because this behavior
was more variable, only licking responses were recorded. We
found that the Runx1 CKO mice displayed licking responses
indistinguishable from their WT littermates (Figure 4C), suggest-
ing that Runx1 is dispensable for this type of visceral pain. In
contrast, the duration of licking response was greatly reduced
in the Runx1 GOF mice compared to their WT littermates, sug-
gesting a marked impairment of visceral pain (Figure 4D). We
previously reported a reduction in TRPV1-expressing DRG neu-
rons in the Runx1 GOF mice (Abdel Samad et al., 2010) and now
show here a marked loss of general colon innervation in these
mutants (see Figure 3). Thus, a possible loss of TRPV1+ fibers in
the GOF colon might account for the impairment of capsaicin-
evoked pain compared to the WT mice, although our data could
not rule out that the pain defect is caused by a loss of expression
of TrkA or other Runx1-suppressed genes in GOF mice.
Collectively, these results suggest that Runx1-dependent
DRG neurons are dispensable for sensing deep tissue pain;
instead, those DRG neurons whose development requires extin-
guishment of Runx1 expression are involved with muscle pain
and visceral pain.
DISCUSSION
Developmental Segregation of Cutaneous versus Deep
Tissue Pain Sensory Neurons
The study described here illustrates a genetic program that con-
trols the segregation of two topographically distinct populations
of pain-related sensory neurons. Runx1-dependent neurons
innervate the most superficial ectodermal tissues and control
cutaneous pain, whereas neurons whose development requires
downregulation or a lack of Runx1 expression innervate the deep
mesodermal/endodermal tissues and control deep tissue pain
(summarized in Figure 4E).
Runx1-dependent neurons (Mrgprd+, Mrgpra3+, Mrgprb4+,
VGLUT3+, Trpm8+, and TRPV1high) are composed of a variety
of sensory modalities, involved with the detection of pain, itch,
temperature, and/or sensory touch (Han et al., 2013; Knowlton
et al., 2013; Liu and Ma, 2011; Lou et al., 2013; McKemy,
2013; Pogorzala et al., 2013; Vrontou et al., 2013). Several lines
of evidence demonstrated in this study support the model that
Runx1-dependent neurons predominantly innervate epidermal
tissues. First, genetic marking described here (Figure S1) and
previously demonstrates that several Runx1-dependent sensory
neurons, including VGLUT3+, Mrgprd+, Mrgpra3+, and Mrgprb4+
innervate the skin epidermis and hair follicles, but not the deep
tissues such as the muscle and the bladder (Cavanaugh et al.,
2009; Han et al., 2013; Rau et al., 2009; Zylka et al., 2005).
Consistently, in Runx1 CKO mice, although innervation to the
skin epidermis is greatly reduced, no obvious loss is observed
in muscle or visceral organs (Figures 2). Second, in contrast to
marked deficits in sensing cutaneous pain (Chen et al., 2006),Cell Retwo types of deep tissue pain tested here, muscle pain induced
by hypertonic solution injection and visceral pain induced by
intracolonic capsaicin injection, are preserved in Runx1 CKO
mice (Figure 4).
Peripheral tissues develop from different germ layers, with
superficial tissues being derived primarily from the ectoderm,
and the deep tissues being derived primarily from the mesoderm
and endoderm. Interestingly, the innervation of Runx1-depen-
dent neurons extends not only to the epidermis, but to other non-
cutaneous tissues that are also derived from the ectoderm. For
example, Mrgprd+ neurons do not innervate mesoderm-derived
bone tissues in the leg (Jimenez-Andrade et al., 2010) but do
innervate the tooth pulp, which, although considered a bone tis-
sue, is actually derived from the ectoderm (Chung et al., 2012;
Gilbert, 2000). TRPM8+ neurons also innervate the tooth pulp,
as well as the cornea, another ectoderm-derived tissue (Dhaka
et al., 2008; Gilbert, 2000; Parra et al., 2010; Takashima et al.,
2007). Only less than 1%of bladder-innervating neurons express
Runx1-dependent TRPM8 (Hayashi et al., 2009). Thus, Runx1 is
required predominantly, but not exclusively, for the development
of sensory neurons innervating ectodermal tissues.
Within cutaneous sensory neurons, Runx1 also acts as a ge-
netic repressor to prevent these neurons from acquiring a large
molecular program represented by Runx1-suppressed genes.
We recognize two categories of Runx1-suppressed genes.
One is relatively broadly expressed in DRG neurons, such as
CGRP. We reported previously that Runx1-mediated CGRP
repression is context dependent (Abdel Samad et al., 2010),
and this Runx1-suppressed gene is in fact associated with
both Runx1-dependent cutaneous neurons, such as Mrgpra3+
and TRPA1+ neurons (Abdel Samad et al., 2010; Han et al.,
2013; Story et al., 2003), and Runx1-independent deep tissue
neurons (Figure S1). The other category of Runx1-suppressed
genes, however, is expressed in small subsets of Nav1.8 lineage
neurons that innervate the deep tissues, and their expression
is excluded from major populations of Runx1-dependent cuta-
neous sensory neurons (Figures 1 and S1). One of these genes
is Prokr2, and our genetic fate mapping demonstrates that the
Prokr2-Cre mouse line can be used to mark DRG neurons that
innervate the deep tissues but not the superficial cutaneous
tissues. Like Runx1-dependent cutaneous sensory neurons,
deep tissue sensory neurons are heterogeneous. First, neurons
innervating the bladder show a different molecular profile than
neurons innervating the muscle (Figure 1). Second, muscle-
innervating neurons are both peptidergic and nonpeptidergic,
as demonstrated by Pcdh21+ and Serpinb1b+ neurons, respec-
tively (Figure S1). This heterogeneity is consistent with the exis-
tence of different populations ofmuscle afferents that respond to
different types of stimuli (Jankowski et al., 2013).
The mechanism by which Runx1 prevents cutaneous sensory
neurons from acquiring the molecular identities belonging to
deep tissue Nav1.8 lineage neurons is still unknown. Besides a
transcriptional activation domain, Runx1 also contains a C-ter-
minal peptide capable of binding the Groucho class transcrip-
tional repressor complex and thus can act as a direct repressor
(Nishimura et al., 2004) (Figure S3). We found that removal of this
repression domain in D446 mice did not cause an expansion of
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(Figure S3B), which is contrast to the marked expansion
observed in Runx1 CKO mice (Figure S1). Thus, Runx1 does
not use its C-terminal repression domain to suppress these
Runx1-suppressed genes within cutaneous sensory neurons.
Consistent with the association of Runx1-suppressed genes
with deep tissue sensory neurons, Runx1 is not detected in these
neurons at adult ages (Figure 3). We reported previously that a
vast majority of embryonic TrkA+ neurons (93%) express
Runx1 (AbdelSamadet al., 2010), andabouthalf of theseneurons
retain TrkA but switch off Runx1 during perinatal and postnatal
development (Chen et al., 2006). A majority of Ptgir+ neurons
are TrkA+ (Figure S1), suggesting a transient Runx1 expression
in these deep tissue neurons. The GOF studies further suggest
that downregulation or exclusion of Runx1 is a prerequisite for
the acquisition of the Runx1-suppressed molecular program in
deep tissue DRG neurons. However, our data do not rule out
the possibility that early transient Runx1 expression might play
a role in establishingcertainunknown featuresof deep tissuesen-
sory neurons, just as early transient TrkAexpression is required to
establish molecular identities of Runx1-dependent cutaneous
sensory neurons (Luo et al., 2007). Thus, future studies are
needed to determine if there is any deep tissue pain not tested
here that is impaired in Runx1 knockout mice.
There is a well-documented difference between cutaneous
and deep tissue pain, with the former one generating more re-
flexive or protective responses and the latter one associated
with more emotional and autonomic responses (Bove et al.,
2009; McMahon et al., 1995; Ness and Gebhart, 1990; Robinson
and Gebhart, 2008). It is interesting to note that Runx1 also plays
a role in guiding Runx1-dependent neurons to innervate inner
lamina II of the dorsal horn of the spinal cord, and a knockout
of Runx1 leads to a switch of innervation to more superficial
laminae (Chen et al., 2006). Combined with our current finding
that Runx1 is required predominantly for the development of
the cutaneous sensory neurons, these Runx1 activities may
form a developmental basis for allowing cutaneous and deep tis-
sue pain to be processed along distinct central pathways, even
though some spinal neurons do receive convergent inputs
from these two pathways (Brumovsky and Gebhart, 2010; Willis
and Westlund, 2001).
Implications on Pain Treatment
Theexistenceof twomolecularlydistinct painpathwayshighlights
thenecessity for thedevelopmentofdistinct strategies for treating
pain originating from cutaneous versus deep tissues. Notably,
although most clinical cases of pain originate from deep meso-
dermal and endodermal tissues, themajority of current preclinical
studies measure pain from the skin. This discrepancy might
contribute to the lack of success in the translation of preclinical
animal models into human pain medications (Mogil, 2009).
It should be pointed out that among the six Runx1-suppressed
genes presented in this study, five are expressed in neurons
innervating the muscle (Figure 1), bone, or joint (data not shown).
Their expression is excluded not only from known cutaneous
neurons but also from neurons innervating the bladder or the
colon (Figure 1; data not shown), suggesting that a majority of
Runx1-suppressed genes may preferentially mark sensory neu-
rons projecting to mesodermal tissues. Accordingly, drugs tar-1362 Cell Reports 5, 1353–1364, December 12, 2013 ª2013 The Autgeted at DRG neurons expressing this set of Runx1-suppressed
genes might be ideal for treating pain originating from the mus-
cle, bone, and/or joint because they would be less likely to cause
side effects on cutaneous somatic sensations (such as the sense
of temperature) or visceral organ functions, both of which are
vital for our daily life. Thus, as we enter an era of considering
personalized pain medicine (von Hehn et al., 2012), the exis-
tence of molecularly distinct DRG neurons innervating specific
peripheral targets suggests that we should consider ‘‘tissue/
organ-based’’ pain medicines, as well.
EXPERIMENTAL PROCEDURES
All animal handling, surgeries, and behavioral test protocols (described below
and in the Supplemental Experimental Procedures) were approved by the
Institutional Animal Care and Use Committee at the Dana-Farber Cancer
Institute. Detailed protocols and information on the mouse lines are listed in
Supplemental Experimental Procedures.
Microarray analyses were performed using L4–L5 lumbar DRGs from P60-
P90 Runx1F/F control and Wnt1Cre;Runx1F/F CKO animals.
In situ hybridization, immunohistochemistry, and IB4 labeling were per-
formed using established procedures.
For the retrograde labeling studies in themuscle, 2–4 ml of FluoroGold was in-
jected into one site in the gastrocnemius muscle, and lumbar DRGs were
dissected out after 1 week. Retrograde labeling studies in the bladder and the
colonwereperformedaspreviouslydescribed (Christiansonetal., 2006b,2007).
Muscle pain behavior was done by injecting 100 ml isotonic saline (IS, 0.9%
NaCl) or hypertonic saline (HS, 5% NaCl) into both gastrocnemius muscles of
adult mice. The mice were immediately placed upon an accelerating rotarod,
and performance wasmeasured by time spent on the rotarod before falling off.
The intracolonic capsaicin assay was done by injecting 50 ml 0.1% capsaicin
into the colon via the anus as previously described (Laird et al., 2001). The
number of licking behaviors around the abdomen, back of the tail, the tail itself,
and the hindlimbs were measured within a 20 min period.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2013.11.005.
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